These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5114497)

  • 1. Changes in liver blood flow during enzyme induction.
    Ohnhaus EE; Thorgeirsson SS; Davies DS; Breckenridge A
    Biochem Pharmacol; 1971 Oct; 20(10):2561-70. PubMed ID: 5114497
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of age and diet on the induction of microsomal enzymes in the mouse.
    Hospador MA; Grosso LS; Manthei RW
    Proc Soc Exp Biol Med; 1971 Mar; 136(3):884-8. PubMed ID: 4396668
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of drug metabolism. I. Differences in the mechanisms by which polycyclic hydrocarbons and phenobarbital produce their inductive effects on microsomal N-demethylating systems.
    Sladek NE; Mannering GJ
    Mol Pharmacol; 1969 Mar; 5(2):174-85. PubMed ID: 5787084
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat.
    Nies AS; Wilkinson GR; Rush BD; Strother JR; McDevitt DG
    Biochem Pharmacol; 1976 Sep; 25(17):1991-3. PubMed ID: 985528
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of drug metabolism. II. Qualitative differences in the microsomal N-demethylating systems stimulated by polycyclic hydrocarbons and by phenobarbital.
    Sladek NE; Mannering GJ
    Mol Pharmacol; 1969 Mar; 5(2):186-99. PubMed ID: 5787085
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of microsomal drug hydroxylation in lung and liver of various species.
    Oppelt WW; Zange M; Ross WE; Remmer H
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):43-56. PubMed ID: 5524315
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on the relationship of the stimulatory effects of phenobarbital and 3,4-benzpyrene on hepatic heme synthesis to their effects on hepatic microsomal drug oxidations.
    Baron J; Tephly TR
    Arch Biochem Biophys; 1970 Aug; 139(2):410-20. PubMed ID: 4322802
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of enzyme inducers on substrate specificity of the cytochrome P-450's.
    Conney AH; Lu AY; Levin W; Somogyi A; West S; Jacobson M; Ryan D; Kuntzman R
    Drug Metab Dispos; 1973; 1(1):199-210. PubMed ID: 4129867
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spectral properties of cytochrome P450 following induction with phenobarbital, benzopyrene and methylcholanthrene].
    Remmer H; Greim G; Hildebrandt A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):189-90. PubMed ID: 4239220
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3'-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat.
    Welch RM; Gommi B; Alvares AP; Conney AH
    Cancer Res; 1972 May; 32(5):973-8. PubMed ID: 5017744
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of new methods to measure: the effect of diet and inducers of microsomal enzyme synthesis on cytochrome P-450 in liver homogenates, and on metabolism of dimethyl nitrosamine.
    McLean AE; Day PA
    Biochem Pharmacol; 1974 Apr; 23(7):1173-80. PubMed ID: 4823450
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of suramin (Bayer 205) on hepatic microsomal cytochromes P-450, b 5 , and demethylation activity in rats.
    Basu TK; Stewart PS; Harris RG; Williams DC
    Biochem Pharmacol; 1973 Apr; 22(8):987-9. PubMed ID: 4693831
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.
    Feller DR; Gerald MC
    Biochem Pharmacol; 1971 Aug; 20(8):1991-2000. PubMed ID: 4400282
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased effect of phenobarbital treatment on microsomal drug metabolizing enzyme activity during gestation.
    Schlede E; Borowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):341-55. PubMed ID: 4275256
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of age and diet on the induction of hexobarbital-metabolizing enzymes in the mouse.
    Hospador MA; Manthei RW
    Proc Soc Exp Biol Med; 1968 May; 128(1):130-2. PubMed ID: 4385350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of inducing agents on drug-oxidising and other redox enzymes in liver].
    Koransky W; Magour S; Noack G; Hermann RS
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(2):281-96. PubMed ID: 4181230
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminopyrine demethylase. Kinetic evidence for multiple microsomal activities.
    Pederson TC; Aust SD
    Biochem Pharmacol; 1970 Jul; 19(7):2221-30. PubMed ID: 5520370
    [No Abstract]   [Full Text] [Related]  

  • 20. Some studies and comments on hepatic and extrahepatic microsomal toxication-detoxication systems. A limited discussion of some of the heterogeneities of these systems and of their responses to stimulation of enzyme "induction".
    Fouts JR
    Environ Health Perspect; 1972 Oct; 2():55-66. PubMed ID: 4404490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.